CXAI:NASDAQCXApp Inc. Analysis
Data as of 2026-03-28 - not real-time
$0.19
Latest Price
8/10Risk
Risk Level: High
Executive Summary
CXApp Inc. (CXAI) is trading at $0.19, well below its 20‑day SMA of $0.23 and 50‑day SMA of $0.24, indicating a bearish price position. The MACD histogram is negative and the signal line is labeled “bearish,” while the RSI sits at 42, suggesting limited upside momentum. Volatility is extreme at 139% over the past 30 days and the 30‑day max drawdown exceeds 88%, underscoring a highly unstable price environment. Fundamentals are weak: the company reports negative earnings per share, a trailing PE of 0, operating margins of –3.4%, and a cash balance that is eclipsed by $6.86 M of debt, yielding a debt‑to‑equity of 45%. Recent news highlights product launches and a new spatial‑intelligence layer, yet the firm has just received a 180‑day Nasdaq extension to regain the $1 minimum bid price, reflecting ongoing compliance pressure. Liquidity is eroding, with a decreasing volume trend despite a modest average daily volume relative to its $9 M market cap.
Given the confluence of bearish technical signals, severe financial strain, and regulatory headwinds, short‑term prospects appear dim, while any long‑term upside would depend on a successful turnaround of its AI‑driven workplace platform and a restoration of price compliance.
Given the confluence of bearish technical signals, severe financial strain, and regulatory headwinds, short‑term prospects appear dim, while any long‑term upside would depend on a successful turnaround of its AI‑driven workplace platform and a restoration of price compliance.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical indicators (price below SMAs, MACD bearish)
- Nasdaq compliance extension indicating price pressure
- Negative earnings and high cash burn
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential revenue upside from new AI workplace products
- Continued cash‑flow deficits and debt load
- Elevated volatility and liquidity concerns
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Significant upside potential if turnaround succeeds
- Persistent structural financial weakness
- Regulatory compliance risk remains until price exceeds $1
Key Metrics & Analysis
Financial Health
Revenue Growth-41.30%
Profit Margin-215.40%
P/E Ratio-0.3
ROE-76.23%
ROA-30.15%
Debt/Equity45.04
P/B Ratio0.3
Op. Cash Flow$-9446000
Free Cash Flow$-7218375
Industry P/E32.0
Technical Analysis
TrendBearish
RSI41.9
Support$0.16
Resistance$0.32
MA 20$0.23
MA 50$0.24
MA 200$0.60
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98
Valuation
Target Price$2.00
Upside/Downside929.34%
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.18
Volatility139.31%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.